Endophthalmitis is a devastating ocular disorder that leads to visual blindness. Rapid detection and identification of the causative pathogens is crucial for vision-saving diagnosis and treatment.

Takara Bio Inc., a biotechnology company in Otsu, Japan, has developed a system which allows for mass production of a wide variety of DNA (deoxyribonucleic acid) fragments needed to make DNA ...

The surge in genomics and proteomics research for disease diagnosis, drug discovery, and personalized medicine is a primary driver of the DNA microarray market. Applications in Disease Diagnostics: ...

As genomics morphs into proteomics and the quest to understand the biological functions of proteins accelerates, researchers continue to look for the best methods that will speed their understanding; ...

NEWARK, Del, March 19, 2024 (GLOBE NEWSWIRE) -- The DNA microarray market is estimated to be worth US$ 4.1 billion in 2024 and is projected to be valued at US$ 9.9 billion in 2034. Between 2024 and ...

The late 1980s were heady days for molecular biologists. PCR was only a few years old. The automated DNA sequencer had just been invented. The Human Genome Project was being debated in Congress.

According to a recent report by Market.us, the Global DNA Microarray Market size is expected to be worth around USD 4,593.7 Million by 2033 from USD 1,994.6 Million in 2023, growing at a CAGR of 8.7% ...